Gainers
- Protagonist Therapeutics, Inc. PTGX shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical studies. Northland Capital Markets upgraded the stock from Market Perform to Outperform.
- Adamas Pharmaceuticals, Inc. ADMS gained 74% to $8.04. Supernus Pharmaceuticals agreed to acquire Adamas Pharmaceuticals for $9.10 per share, or $450 million.
- Flexion Therapeutics, Inc. FLXN gained 60.9% to $9.30. Pacira BioSciences agreed to acquire Flexion Therapeutics for $8.50 per share in cash, plus one contingent value right (CVR) worth up to $8.00 per share in cash.
- U.S. Well Services, Inc. USWS jumped 29.6% to $3.1099 in sympathy with the price of oil amid increased demand and limited supply.
- EZFill Holdings Inc. EZFL surged 17% to $4.0790 after the company announced it has purchased 33 additional fuel trucks, more than tripling the size of its delivery fleet.
- Blue Apron Holdings, Inc. APRN gained 16.2% to $7.95.
- Gaotu Techedu Inc. GOTU rose 16% to $3.9250.
- Ocular Therapeutix, Inc. OCUL surged 15% to $11.21. Traders circulated Oct. 7 FDA approval for the company’s Dextenza.
- Katapult Holdings, Inc. KPLT rose 13.2% to $5.18. Katapult Holdings became an Accelerate partner in the Adobe Exchange Program.
- DatChat, Inc. DATS gained 13% to $13.24.
- TETRA Technologies, Inc. TTI rose 12.8% to $3.86 in sympathy with the price of oil amid increased demand and limited supply.
- Innoviz Technologies Ltd. INVZ gained 12.3% to $5.22.
- Willamette Valley Vineyards, Inc. WVVI surged 11.3% to $14.25.
- Nutriband Inc. NTRB shares gained 10.5% to $7.40 after dropping over 14% on Friday.
- Trevi Therapeutics, Inc. TRVI gained 10% to $1.33 after the company filed Friday to withdraw its offering of shares.
- Matinas BioPharma Holdings, Inc. MTNB rose 8.5% to $1.1501.
- Liquidia Corporation LQDA rose 7.9% to $7.40 after the company received favorable ruling in Inter Partes Review against United Therapeutics patent.
- AIkido Pharma Inc. AIKI shares rose 6.8% to $0.9289. HC Wainwright & Co. initiated coverage on AIkido Pharma with a Buy rating and announced a price target of $2.
Check out these big penny stock gainers and losers
Losers
- Cipher Mining Inc. CIFR shares dropped 18.8% to $6.41.
- AeroCentury Corp. ACY shares fell 14% to $52.44.
- SecureWorks Corp. SCWX shares declined 13.3% to $20.13.
- Voyager Therapeutics, Inc. VYGR dropped 11.3% to $4.92 after jumping around 45% on Friday.
- PagSeguro Digital Ltd. PAGS fell 11.1% to $32.51 after dropping 19% on Friday.
- MeaTech 3D Ltd. MITC dropped 10.3% to $7.62. Meatech 3D recently said it is partnering with a collective led by Ashton Kutcher and Guy Oseary, together with strategic players like Effie Epstein, to accelerate growth in developing, commercializing cultured meat production technologies.
- eFFECTOR Therapeutics, Inc. EFTR fell 9.7% to $10.69. eFFECTOR Therapeutics, in collaboration with Baylor College of Medicine, recently announced the presentation of new positive data for zotatifin in animal models of triple-negative breast cancer (TNBC).
- Hyliion Holdings Corp. HYLN dropped 9% to $7.11 after UBS downgraded the stock from Neutral to Sell and lowered its price target from $14 to $5.
- BEST Inc. BEST fell 8.2% to $1.8997.
- Ginkgo Bioworks Holdings, Inc. DNA dropped 7.5% to $9.56.
CIFRCipher Mining Inc
$5.902.79%
DATSDatChat Inc
$1.787.88%
DNAGinkgo Bioworks Holdings Inc
$10.0615.1%
EFTReFFECTOR Therapeutics Inc
$0.078339050.0%
EZFLEzFill Holdings Inc
$3.39-3.69%
GOTUGaotu Techedu Inc
$2.330.87%
HYLNHyliion Holdings Corp
$2.758.70%
INVZInnoviz Technologies Ltd
$1.137.62%
KPLTKatapult Holdings Inc
$6.938.45%
LQDALiquidia Corp
$10.50-0.85%
MTNBMatinas BioPharma Holdings Inc
$0.5521-2.56%
NTRBNutriband Inc
$4.605.50%
OCULOcular Therapeutix Inc
$8.632.13%
PAGSPagSeguro Digital Ltd
$6.402.24%
PTGXProtagonist Therapeutics Inc
$41.494.93%
SCWXSecureWorks Corp
$8.470.24%
TRVITrevi Therapeutics Inc
$4.01-3.37%
TTITetra Technologies Inc
$3.42-0.58%
VYGRVoyager Therapeutics Inc
$5.751.05%
WVVIWillamette Valley Vineyards Inc
$3.350.60%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in